Exact Mass: 458.1927
Exact Mass Matches: 458.1927
Found 319 metabolites which its exact mass value is equals to given mass value 458.1927
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Austinol
Austinol is a metabolite of Emericella nidulans, Emericella dentata, Aspergillus variecolor and Aspergillus ustu Metabolite of Emericella nidulans, Emericella dentata, Aspergillus variecolor and Aspergillus ustus.
Fluprostenol
Lexipafant
7-[2,5-Dihydroxy-2-[3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoic acid
15(S)-Fluprostenol
8,9-Dihydro,8-hydroxy-Exiguaflavanone D|exiguaflavanone M
3,4,5,7-tetrahydroxy-6-[7-hydroxy-3,7-dimethyl-2(E)-octenyl]flavanone
8beta-<5-(4-hydroxytigloyl)-4-hydroxytigloyloxy>-kauniolide|8beta-[5-(4-hydroxytigloyl)-4-hydroxytigloyloxy]-kauniolide
8beta-<5-<4,5-dihydroxytigloyloxy>-tigloyloxy>-kauniolide|8beta-[5-(4,5-dihydroxytigloyloxy)-tigloyloxy]-kauniolide
Ligustrin-<5-O-(4-hydroxytigloyl)-4-hydroxy>-sarracinate|Ligustrin-[5-O-(4-hydroxytigloyl)-4-hydroxy]-sarracinate
8beta-4-hydroxy-5-(tigloyloxy)-tigloyloxy-4beta,15-dihydro-3-dehydrozaluzanin C
desacetoxyzuubergenin-8beta-4-hydroxy-5-(5-hydroxysarracinoyl)-tiglate
8beta-5-(5-hydroxytigloyloxy)-tigloyloxy-3-dehydro-4beta,15-dihydro-zaluzanin C|8beta-5-<5-hydroxytigloyloxy>-tigloyloxy-3-dehydro-4beta,15-dihydro-zaluzanin C
1-[2,3-trans-3,4-dihydroxy-2-(1,4-dihydroxy-1,5-dimethylhex-5-enyl)-2,3-dihydrobenzofuran-5-yl]-3-(4-hydroxyphenyl)-E-propenone|xanthokeismin C
8beta,9alpha-diangeloyloxy-14-oic-acanthospermolide
8beta,9alpha-diangeloyloxy-15-hydroxy-14-oxo-4,5-cis-acanthospermolide
Ligustrin-<4-hydroxy-5-(5-hydroxytigloyloxy)-tiglate>
Kadsurin
Kadsurin, (-)- is a tannin. It has a role as a metabolite. Kadsurin is a natural product found in Kadsura coccinea, Kadsura heteroclita, and other organisms with data available.
C25H30O8_3-Furancarboxylic acid, (3R,5S,5aS,6S,9aR)-octahydro-9-hydroxy-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-5,6-diyl ester
Ala His Met Thr
Ala His Thr Met
Ala Met His Thr
Ala Met Thr His
Ala Thr His Met
Ala Thr Met His
Cys His Ile Ser
Cys His Leu Ser
Cys His Ser Ile
Cys His Ser Leu
Cys His Thr Val
Cys His Val Thr
Cys Ile His Ser
Cys Ile Ser His
Cys Leu His Ser
Cys Leu Ser His
Cys Ser His Ile
Cys Ser His Leu
Cys Ser Ile His
Cys Ser Leu His
Cys Thr His Val
Cys Thr Val His
Cys Val His Thr
Cys Val Thr His
Asp Asp Ile Pro
Asp Asp Leu Pro
Asp Asp Pro Ile
Asp Asp Pro Leu
Asp Glu Pro Val
Asp Glu Val Pro
Asp Ile Asp Pro
Asp Ile Pro Asp
Asp Leu Asp Pro
Asp Leu Pro Asp
Asp Met Pro Pro
Asp Pro Asp Ile
Asp Pro Asp Leu
Asp Pro Glu Val
Asp Pro Ile Asp
Asp Pro Leu Asp
Asp Pro Met Pro
Asp Pro Pro Met
Asp Pro Val Glu
Asp Val Glu Pro
Asp Val Pro Glu
Glu Asp Pro Val
Glu Asp Val Pro
Glu Pro Asp Val
Glu Pro Val Asp
Glu Val Asp Pro
Glu Val Pro Asp
His Ala Met Thr
His Ala Thr Met
His Cys Ile Ser
His Cys Leu Ser
His Cys Ser Ile
His Cys Ser Leu
His Cys Thr Val
His Cys Val Thr
His Ile Cys Ser
His Ile Ser Cys
His Leu Cys Ser
His Leu Ser Cys
His Met Ala Thr
His Met Thr Ala
His Ser Cys Ile
His Ser Cys Leu
His Ser Ile Cys
His Ser Leu Cys
His Thr Ala Met
His Thr Cys Val
His Thr Met Ala
His Thr Val Cys
His Val Cys Thr
His Val Thr Cys
Ile Cys His Ser
Ile Cys Ser His
Ile Asp Asp Pro
Ile Asp Pro Asp
Ile His Cys Ser
Ile His Ser Cys
Ile Pro Asp Asp
Ile Ser Cys His
Ile Ser His Cys
Leu Cys His Ser
Leu Cys Ser His
Leu Asp Asp Pro
Leu Asp Pro Asp
Leu His Cys Ser
Leu His Ser Cys
Leu Pro Asp Asp
Leu Ser Cys His
Leu Ser His Cys
Met Ala His Thr
Met Ala Thr His
Met Asp Pro Pro
Met His Ala Thr
Met His Thr Ala
Met Pro Asp Pro
Met Pro Pro Asp
Met Thr Ala His
Met Thr His Ala
Pro Asp Asp Ile
Pro Asp Asp Leu
Pro Asp Glu Val
Pro Asp Ile Asp
Pro Asp Leu Asp
Pro Asp Met Pro
Pro Asp Pro Met
Pro Asp Val Glu
Pro Glu Asp Val
Pro Glu Val Asp
Pro Ile Asp Asp
Pro Leu Asp Asp
Pro Met Asp Pro
Pro Met Pro Asp
Pro Pro Asp Met
Pro Pro Met Asp
Pro Val Asp Glu
Pro Val Glu Asp
Ser Cys His Ile
Ser Cys His Leu
Ser Cys Ile His
Ser Cys Leu His
Ser His Cys Ile
Ser His Cys Leu
Ser His Ile Cys
Ser His Leu Cys
Ser Ile Cys His
Ser Ile His Cys
Ser Leu Cys His
Ser Leu His Cys
Thr Ala His Met
Thr Ala Met His
Thr Cys His Val
Thr Cys Val His
Thr His Ala Met
Thr His Cys Val
Thr His Met Ala
Thr His Val Cys
Thr Met Ala His
Thr Met His Ala
Thr Val Cys His
Thr Val His Cys
Val Cys His Thr
Val Cys Thr His
Val Asp Glu Pro
Val Asp Pro Glu
Val Glu Asp Pro
Val Glu Pro Asp
Val His Cys Thr
Val His Thr Cys
Val Pro Asp Glu
Val Pro Glu Asp
Val Thr Cys His
Val Thr His Cys
fluprostenol
D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents D012102 - Reproductive Control Agents > D008186 - Luteolytic Agents C78568 - Prostaglandin Analogue
5-trans Fluprostenol
Austinol
A meroterpenoid produced by Aspergillus nidulans. It has a pentacyclic structure which incorporates three lactone functionalities and a spiro union.
1,3-diisocyanato-2-methylbenzene,ethane-1,2-diol,hexanedioic acid,propane-1,2-diol
(4R,5S)-2-[[(4R,5S)-4,5-diphenyl-4,5-dihydro-1,3-oxazol-2-yl]methyl]-4,5-diphenyl-4,5-dihydro-1,3-oxazole
4-[(2-Amino-1,3-benzothiazol-6-yl)amino]-6-methyl-7-[2-(1-piperid inyl)ethoxy]-3-quinolinecarbonitrile
2-Ethoxy-1-[[2-[(hydroxyamino)iminomethyl][1,1-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid ethyl ester
(2s,4s,5r)-1-(4-Tert-Butylbenzoyl)-2-Isobutyl-5-(1,3-Thiazol-2-Yl)pyrrolidine-2,4-Dicarboxylic Acid
(12R)-5-ethyl-12-(4-methoxyphenyl)-15,17-dimethyl-2,4,9,13-tetraoxatetracyclo[8.7.1.03,8.014,18]octadeca-1(17),14(18),15-triene-6,7,16-triol
7-[2,5-Dihydroxy-2-[3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoic acid
1-[(6,7-dimethoxy-2-oxo-1H-quinolin-3-yl)methyl]-3-(phenylmethyl)-1-(3-pyridinylmethyl)urea
(E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoic acid
N-[(2S,3R,6S)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-4-methylbenzenesulfonamide
N-[(2S,3S,6S)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-4-methylbenzenesulfonamide
N-[(2R,3R,6S)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]-4-methylbenzenesulfonamide
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-fluorophenyl)methyl]acetamide
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxyacetyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(2-fluorophenyl)methyl]acetamide
2-[(3R,6aR,8R,10aR)-3-hydroxy-1-(pyrazine-2-carbonyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(4-fluorophenyl)methyl]acetamide
N-[(2R,3S,6R)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-4-methylbenzenesulfonamide
N-[(2R,3S,6S)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]-4-methylbenzenesulfonamide
N-[(2R,3R,6R)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]-4-methylbenzenesulfonamide
N-[(2S,3S,6R)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-4-methylbenzenesulfonamide
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-fluorophenyl)methyl]acetamide
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-(pyrazine-2-carbonyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(4-fluorophenyl)methyl]acetamide
2-[(3S,6aR,8S,10aR)-3-hydroxy-1-[oxo(2-pyrazinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(4-fluorophenyl)methyl]acetamide
2-[(3S,6aR,8R,10aR)-3-hydroxy-1-[oxo(2-pyrazinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(4-fluorophenyl)methyl]acetamide
2-[(3S,6aS,8S,10aS)-3-hydroxy-1-[oxo(2-pyrazinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(4-fluorophenyl)methyl]acetamide
N-[(2S,3R,6R)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-4-methylbenzenesulfonamide
2-[(3S,6aS,8R,10aS)-3-hydroxy-1-[oxo(2-pyrazinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(4-fluorophenyl)methyl]acetamide
2-[(3R,6aS,8R,10aS)-3-hydroxy-1-[oxo(2-pyrazinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(4-fluorophenyl)methyl]acetamide
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-fluorophenyl)methyl]acetamide
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-fluorophenyl)methyl]acetamide
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-fluorophenyl)methyl]acetamide
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-fluorophenyl)methyl]acetamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[oxo(2-pyrazinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(4-fluorophenyl)methyl]acetamide
[(3aS,4R,9bS)-4-(hydroxymethyl)-8-(2-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(1,3-benzodioxol-5-yl)methanone
FABPs ligand 6
FABPs ligand 6 (MF6) is an FABP5 and FABP7 inhibitor with KD values of 874 nM and 20 nM, respectively. FABPs ligand 6 can be used for multiple sclerosis research[1].